- abnormal adrenal gland morphology / MGI
- abnormal uterus morphology / MGI
- abnormal ovary morphology / MGI
- abnormal ovarian folliculogenesis / MGI
- absent corpus luteum / MGI
- abnormal testis morphology / MGI
- Leydig cell hyperplasia / MGI
- arrest of spermatogenesis / MGI
- small seminal vesicle / MGI
- decreased body weight / MGI
- cyanosis / MGI
- postnatal growth retardation / MGI
- increased circulating corticotropin-releasing hormone level / MGI
- decreased circulating corticosterone level / MGI
- decreased circulating aldosterone level / MGI
- small prostate gland / MGI
- abnormal Leydig cell morphology / MGI
- male pseudohermaphroditism / MGI
- enlarged ovary / MGI
- increased adrenocorticotropin level / MGI
- prostate gland hypoplasia / MGI
- seminal vesicle hypoplasia / MGI
- abnormal adrenal cortex morphology / MGI
- adrenal cortical hyperplasia / MGI
- postnatal lethality, incomplete penetrance / MGI
- neonatal lethality, incomplete penetrance / MGI
C57BL/6NTac-Startm1(EGFP/Cre/ERT2)Wtsi/WtsiH
Status | Available to order |
EMMA ID | EM:11127 |
International strain name | C57BL/6NTac-Startm1(EGFP/Cre/ERT2)Wtsi/WtsiH |
Alternative name | CEPD0062_5_A06 |
Strain type | Targeted Mutant Strains : Knock-in |
Allele/Transgene symbol | Startm1(EGFP/Cre/ERT2)Wtsi |
Gene/Transgene symbol | Star |
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from EUCOMM ES clone CEPD0062_5_A06. For further details on the construction of this clone see the page at the IMPC portal. Quality Control/Disclaimer: The structure of the targeted mutation is not fully verified. It is recommended that the recipient confirms the mutation structure by Southern blotting. The Cre expression pattern is expected to mirror that of the host gene, but this may not be fully described and/or may be modified in the targeted allele. Although characterisation of the Cre expression pattern is an objective of EUCOMMTools this is an ongoing process which may be incomplete. It is therefore recommended that the recipient verifies the Cre expression pattern. For the tm1(EGFP/Cre/ERT2) type allele, if the promoter-driven selection cassette is flanked with Rox sites, it may be removed using Dre recombinase. Please be aware that the strain description may be subject to change. For the most recent description please consult the information pages for the appropriate product details at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Animals used for archiving | heterozygous C57BL/6NTacUSA, heterozygous C57BL/6NTacUSA |
Breeding at archiving centre | C57BL/6NTac background |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Non-classic congenital lipoid adrenal hyperplasia due to STAR deficency / Orphanet_325529
- Classic congenital lipoid adrenal hyperplasia due to STAR deficency / Orphanet_325524
- Congenital sodium diarrhea / Orphanet_103908
- Chronic infantile diarrhea due to guanylate cyclase 2C overactivity / Orphanet_314373
- Intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency / Orphanet_314376
MGI phenotypes (gene matching)
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).